NCT06449664Recruiting
Training for Men Undergoing Androgen Deprivation Therapy.
ADT-Train - A New Training Concept for Men With Prostate Cancer Receiving Androgen Deprivation Therapy.
Source: ClinicalTrials.gov · Last updated 10 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the effects of a newly developed training concept on men with prostate cancer undergoing androgen deprivation therapy (ADT). The main questions it aims to answer are: * How feasible and safe is the new training concept? * How efficient is the training concept to counteract side effects caused by ADT? Researchers will compare the new training concept with usual care to evaluate how efficient the training concept is to counteract the ADT-related side effects. Participants in the intervention group will perform the new training concept twice weekly for 12 weeks. Participants in the control group will only receive usual care. All participants will visit the laboratory at baseline and after 6 and 12 weeks to measure the primary and secondary outcomes.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 4 Apr 2024
- Start date
- 1 May 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- The Swedish School of Sport and Health Sciences
- Diseases
- Prostate cancer
- NCT number
- NCT06449664
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 May 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- on-going or previously treated with ADT or other hormonal treatments
Other illness
- very high risk localised prostate cancer planned for radiotherapy and ADT plus abiraterone and cortisone
- localized prostate cancer planned for radiotherapy without ADT
Other
- have any contraindications to physical testing/exercise as per the ACSM guidelines
- unable to comply with study procedures
Who the study is looking for
- signed informed consent
- histologically confirmed localised or locally advanced prostate cancer
- planned radiotherapy in combination with ADT for at least six months (unfavorable intermediate risk and high-risk prostate cancer) with curative intent and with no known metastasis.
Age in the registry: 50 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Swedish School of Sport and Health Sciences Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.